InvestorsHub Logo
Followers 17
Posts 6594
Boards Moderated 0
Alias Born 03/06/2010

Re: None

Wednesday, 11/15/2023 7:53:03 PM

Wednesday, November 15, 2023 7:53:03 PM

Post# of 400951
Very nice earnings call. Love the forward looking insights. Vyvanse has already been submitted awaiting acceptance response next month. Expecting 4 approvals next year. Solid efficient supply chain strategy with focus on fewer FDA submissions, but all larger products. Laser focused.

Carter did say we still had term loan…eye roll. Boomerang Carter lol
Volume:
Day Range:
Bid:
Ask:
Last Trade Time:
Total Trades:
  • 1D
  • 1M
  • 3M
  • 6M
  • 1Y
  • 5Y
Recent ELTP News